MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in real-time
Study finds immune cells in glioblastoma use fructose to evade immune response, pointing to a new treatment target
Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross expander system.
Revolve Surgical announced today that it received FDA 510(k) clearance for its surgical robot platform.
Perfuze announced today that it received FDA 510(k) clearance for its Millipede88 aspiration catheter.
Researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also being able to deliver healing agents in one simple, scalable platform.
Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu Jiang at Shandong University, Qingdao, China and colleagues suggests that Escherichia coli Nissle 1917 (EcN) may be engineered with anticancer agents to treat cancerous tumors in mice.
An international research team led by the Levenberg Laboratory in the Faculty of Biomedical Engineering at the Technion-Israel Institute of Technology has succeeded in developing a first-of-its-kind, three-dimensional implant that combines muscle and fat tissues, a lymphatic network, and a hierarchical blood vessel network.
A new study, published in Nature, outlines a method combining smartwatches and routine blood tests to better detect insulin resistance in its early stages, and its early validation testing has shown good accuracy.
510(k) clearance enables immediate U.S. commercialization of enhanced soft tissue approximation technology in the gastrointestinal tract